{"lastClose": 5.190000057220459, "len": 954, "date": "2023-01-17", "alpha_1": -0.7082493129728591, "beta_1": 0.9057921763001656, "drawup_1": 0.7155424508464454, "natr_1": 17.40850159847474, "sup_1": -1.0931277966139175, "res_1": 0.7116249069715826, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 46.473027239472785, "adx_1": 17.59723963782917, "drawdown_1": -0.8070175398354672, "stratHoldSharpe_1": -0.5250221977500015, "stratHoldAlpha_1": 250.55859839960542, "stratHoldDrawdown_1": -0.7334133343768034, "alpha_3mo": -0.17655796444028315, "beta_3mo": 1.6282283280612817, "drawup_3mo": 0.31460677648851965, "natr_3mo": 17.40850159847474, "sup_3mo": -0.03275531299030275, "res_3mo": 0.08092486929930388, "bullPattern_3mo": ["HAMMER"], "bearPattern_3mo": [], "rsi_3mo": 57.78688284313591, "adx_3mo": 19.072715810543496, "drawdown_3mo": -0.2358974593056159, "stratHoldSharpe_3mo": 1.1634419451012554, "stratHoldAlpha_3mo": 251.77760041439552, "stratHoldDrawdown_3mo": -0.21736089020442018, "Country": "United States", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2019.0, "Name": "NGM Biopharmaceuticals Inc.", "Sector": "Health Care", "Market Cap": 423341265, "alpha%_1": 0.0312297205401993, "beta%_1": 0.4430449359456934, "drawup%_1": 0.7365754795884644, "natr%_1": 0.9999999819263149, "drawdown%_1": 0.019849043109208712, "stratHoldSharpe%_1": 0.2428608967862661, "stratHoldAlpha%_1": 0.057382222921831996, "stratHoldDrawdown%_1": 0.020490790435641844, "alpha%_3mo": 0.298968631516181, "beta%_3mo": 0.8767624427729281, "drawup%_3mo": 0.6273382884135417, "natr%_3mo": 0.9999999760573541, "drawdown%_3mo": 0.24149568629146417, "stratHoldSharpe%_3mo": 0.3694549954061864, "stratHoldAlpha%_3mo": 0.6232271514636814, "stratHoldDrawdown%_3mo": 0.23459974275778533}